Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria

CRESY · NASDAQ

Low target$0.00
Average target$0.00
High target$0.00

Analyst ratings

hold · 0 ratings

DateFirmActionRatingPrice target

Prediction markets

Live event probabilities associated with this company or market.

Polymarket

Rio Grande do Sul Governor Election Winner

Luciano Zucco

44.5%Volume 82.49K

Valuation: Deep undervaluation vs. misleading premium pricing

Bull case

CRESY trades at an extremely low price-to-earnings ratio of 1.51 and a price-to-sales of 0.54, with a forward dividend yield of 8.52% and total yield of 11.81%. At current levels, the stock is considered undervalued with strong growth potential, suggesting significant upside for long-term investors.

Bear case

Morningstar places CRESY's fair value at $81.43 yet flags it as trading at a 248% premium with high uncertainty, reflecting deep inconsistency in valuation models. This ambiguity, combined with a -11.31% year-to-date decline in Argentine markets, raises serious doubts about near-term pricing reliability.

Agricultural and real estate diversification: Strategic strength vs. operational complexity

Bull case

Cresud's dual exposure to Argentina's agricultural sector — covering oilseed grains, cereals, sugarcane, and cattle — alongside its real estate arm through IRSA and its shopping malls, offices, and luxury hotels, provides diversified revenue streams that can buffer against sector-specific downturns.

Bear case

Operating across vastly different sectors — from farming in Argentina and Brazil to urban real estate — introduces significant management complexity and capital allocation challenges. Cresud's early redemption of its Series XLIV Notes at a 101% premium signals financial stress and prioritization of debt management over growth investment.

IRSA subsidiary outlook: Upside catalyst vs. conglomerate discount risk

Bull case

Cresud holds a 51.57% stake in IRSA, which carries an average analyst 12-month price target of $21.33, implying a +41.47% upside from current levels. With 3 analyst buy ratings and zero sell recommendations, IRSA represents a compelling embedded value driver within Cresud's portfolio.

Bear case

Despite IRSA's standalone buy consensus, its current trading price of $15.08 significantly lags analyst targets, and Cresud's controlling stake may result in a conglomerate discount. Analysts project only modest 16.60%–30.44% earnings growth for Cresud in 2026, suggesting the IRSA upside may not fully translate to CRESY shareholders.